comparemela.com
  1. Home
  2. Live Updates
  3. Single Pill - Breaking News

Latest Breaking News On - Single pill - Page 6 : comparemela.com

APONTIS PHARMA extends portfolio for the treatment of hypertension and hyperlipidemia by in-licensin

EQS-News: APONTIS PHARMA AG / Key word(s): Product LaunchAPONTIS PHARMA extends portfolio for the treatment of hypertension and hyperlipidemia by in-licensing a new Single Pill 31.01.2023 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announcement.APONTIS PHARMA extends portfolio for the tr.

Sven paulyKarlheinz gastEuropean unionDistribution servicesProduct launchSingle pillSingle pillsNew england journalChief executive officerCorporate newsRegulatory announcements

APONTIS PHARMA confirms 2022 forecast after successful nine-month period – Strong Single Pill pipeline to achieve medium-term targets

EQS-News: APONTIS PHARMA AG / Key word: 9 Month figures/Quarterly / Interim Statement APONTIS PHARMA confirms 2022 forecast after successful nine-month period – Strong Single Pill. | November 10, 2022

Comunidad autonoma de catalunaSven paulyThomas zimmermannKarlheinz gastThomas milzEuropean society of cardiology congressCondensed group statement of cashCondensed group balance sheetUnaudited groupCondensed group income statementStrong single pillSingle pillNew england journalSingle pillsEuropean societyCardiology congress

EQS-News: APONTIS PHARMA announces cooperation to launch new Single Pill in Germany

EQS-News: APONTIS PHARMA AG / Key word(s): Alliance/Product Launch APONTIS PHARMA announces cooperation to launch new Single Pill in .

Sven paulyKarlheinz gastSingle pillSingle pillsMulti pillChief executive officer

iPhone 14 Pro Expected to Feature Larger Battery Alongside Always-On Display

The iPhone 14 Pro and iPhone 14 Pro Max will feature physically larger batteries, according to Bloomberg's Mark Gurman, likely to compensate for.

Mark gurmanBloomberg mark gurmanSingle pillApple watch seriesApple watchAirpods proIphone 14 proMark gurman

DGAP-News: APONTIS PHARMA: SECURE study and START study add-on analysis confirm superior efficacy of Single Pill

DGAP-News: APONTIS PHARMA AG / Key word(s): Scientific publication APONTIS PHARMA: SECURE study and START study add-on analysis confi.

New yorkUnited statesComunidad autonoma de catalunaSven paulyKarlheinz gastInvestigaciones cardiovasculares carlosValentin fusterBurkhard weisserBurkhard weisser kielEuropean society of cardiology congressEuropean union horizonEuropean congressKiel universityMount sinai medical centerEuropean unionEuropean society

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.